155 related articles for article (PubMed ID: 24859319)
1. Design of novel camphane-based derivatives with antimycobacterial activity.
Stavrakov G; Valcheva V; Philipova I; Doytchinova I
J Mol Graph Model; 2014 Jun; 51():7-12. PubMed ID: 24859319
[TBL] [Abstract][Full Text] [Related]
2. Novel camphane-based anti-tuberculosis agents with nanomolar activity.
Stavrakov G; Valcheva V; Philipova I; Doytchinova I
Eur J Med Chem; 2013; 70():372-9. PubMed ID: 24177364
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimycobacterial activity of novel camphane-based agents.
Stavrakov G; Philipova I; Valcheva V; Momekov G
Bioorg Med Chem Lett; 2014 Jan; 24(1):165-7. PubMed ID: 24332625
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of chiral aminoalcohols with camphane scaffold.
Petkova Z; Valcheva V; Momekov G; Petrov P; Dimitrov V; Doytchinova I; Stavrakov G; Stoyanova M
Eur J Med Chem; 2014 Jun; 81():150-7. PubMed ID: 24836067
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
9. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
10. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
Khunt RC; Khedkar VM; Coutinho EC
Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
[TBL] [Abstract][Full Text] [Related]
13. Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives.
Kumar D; Raj KK; Bailey M; Alling T; Parish T; Rawat DS
Bioorg Med Chem Lett; 2013 Mar; 23(5):1365-9. PubMed ID: 23357633
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Leubethanol derivatives and evaluation against Mycobacterium tuberculosis.
Perez-Meseguer J; Del Olmo E; Alanis-Garza B; Escarcena R; Garza-González E; Salazar-Aranda R; Feliciano AS; de Torres NW
Bioorg Med Chem; 2012 Jul; 20(13):4155-63. PubMed ID: 22626551
[TBL] [Abstract][Full Text] [Related]
15. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of indolopyridone hybrids as new antituberculosis agents.
Rather MA; Rasool F; Bhat ZS; Dar HU; Maqbool M; Amin S; Yousuf SK; Ahmad Z
Microb Pathog; 2017 Dec; 113():330-334. PubMed ID: 29079215
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
Khunt RC; Khedkar VM; Chawda RS; Chauhan NA; Parikh AR; Coutinho EC
Bioorg Med Chem Lett; 2012 Jan; 22(1):666-78. PubMed ID: 22104148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
